Acute systemic inflammation exacerbates neuroinflammation in Alzheimer's disease: IL‐1β drives amplified responses in primed astrocytes and neuronal network dysfunction

0301 basic medicine 570 Amyloid Inflammasomes Interleukin-1beta IL-1β disrupted hippocampal gamma rhythm Vulnerability Alzheimer’s disease (AD) Mice, Transgenic Network dysfunction Hippocampus Mice 03 medical and health sciences Neuroinflammation Memory Alzheimer Disease 616 Animals Humans Gamma Cytokine APP/PS1 Inflammation Neurons trigger delirium Delirium Brain 3. Good health IL-1β Chemokine Priming Astrocytes Cytokines Dementia Microglia Primed Astrocyte CCL2
DOI: 10.1002/alz.12341 Publication Date: 2021-06-04T09:33:27Z
ABSTRACT
Neuroinflammation contributes to Alzheimer's disease (AD) progression. Secondary inflammatory insults trigger delirium and can accelerate cognitive decline. Individual cellular contributors this vulnerability require elucidation. Using APP/PS1 mice AD brain, we studied secondary investigate hypersensitive responses in microglia, astrocytes, neurons, human brain tissue. The NLRP3 inflammasome was assembled surrounding amyloid beta, microglia were primed, facilitating exaggerated interleukin-1β (IL-1β) subsequent LPS stimulation. Astrocytes primed produce chemokine intrahippocampal IL-1β. Systemic triggered microglial IL-1β, astrocytic chemokines, IL-6, acute dysfunction, whereas IL-1β disrupted hippocampal gamma rhythm, all selectively mice. Brains from patients with infection showed elevated IL-6 levels. Therefore, leaves the vulnerable inflammation at microglial, astrocytic, neuronal, levels, amplifies neuroinflammatory cytokine synthesis humans. Exacerbation of neuroinflammation deleterious outcomes like accelerated progression merits careful investigation
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (106)
CITATIONS (169)